Issue Date: June 9, 2014
Sequence Of Events
Roche has acquired Genia Technologies, a privately held gene-sequencing company based in Mountain View, Calif. The Swiss drug and diagnostics company is looking to bolster its standing in the next-generation sequencing field after recent setbacks.
Roche sees its purchase as a step toward introducing “a potentially disruptive technology to the market,” says Roland Diggelmann, chief operating officer of Roche Diagnostics. To do so, Roche is willing to pay Genia’s shareholders $125 . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society